Roche

Contact
roche.de
+497624-140

Roche Deutschland Holding GmbH

Emil-Barell-Str. 1
79639 Grenzach-Wyhlen
Germany
+497624-140
roche.de
Contact
Profile Products News
Contact

About Roche

Read more about Roche
Facts about Roche
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Roche

Product portfolio

Show all

News about Roche

Roche

20-Dec-2023 | science

Understanding and fighting tumors better with new algorithms

The University Hospital Zurich, the University of Zurich and the diagnostics company Roche are expanding their collaboration in cancer research. In the ...

Read news
Roche

05-Dec-2023 | business & finance

Billion-euro takeover: Roche joins the fight against obesity

(dpa-AFX) The pharmaceutical company Roche is entering the fight against obesity with a US takeover. The Basel-based company will pay 2.7 billion US ...

Read news
Roche

24-Oct-2023 | business & finance

Roche goes on shopping spree

Billion euro purchase for stomach medicine

Read news
Roche

07-Sep-2022 | business & finance

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes

Read news
Roche

06-Jun-2022 | business & finance

Repare Therapeutics Announces a Worldwide License and Collaboration Agreement with Roche for Camonsertib

Repare Therapeutics Inc. announced it has entered into a worldwide license and collaboration agreement with Roche for the development and commercialization ...

Read news
Roche

24-May-2022 | business & finance

KaliVir Immunotherapeutics Enters into Global Exclusive Licensing Agreement with Roche for Novel Oncolytic Viruses

KaliVir Immunotherapeutics, Inc. announced a collaboration and global exclusive licensing agreement with Roche for the discovery, development and ...

Read news
Roche

23-May-2022 | business & finance

METiS Joins the Roche Accelerator

Start-up combines cutting-edge AI data-driven algorithms, mechanism-driven quantum mechanics and molecular dynamics simulations

Read news
Roche

22-Sep-2020 | business & finance

Start-up Inflazome Announces Acquisition by Roche

Orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases

Read news
Show more news about Roche

Here you will find Roche Deutschland Holding GmbH

See the theme worlds for related content